Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.

Zhiguang Lin, Huiwen Xu,Jingjing Ma,Yan Ma,Qing Li,Hui Kang,Mengxue Zhang,Bobin Chen

Hematology (Amsterdam, Netherlands)（2023）

引用 0|浏览8

暂无评分

摘要

The AT regimen was well tolerated, and patients with specific KIR-HLA genotypes may benefit from this regimen.

查看译文

关键词

Primary central nervous system lymphoma, diffuse large B cell lymphoma, cytarabine, temozolomide, killer cell immunoglobulin-like receptors, chemotherapy, human leukocyte antigen class I, prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要